223 related articles for article (PubMed ID: 34372554)
1. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
[TBL] [Abstract][Full Text] [Related]
2. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
Malik S; Nehra K; Rana JS
Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
[TBL] [Abstract][Full Text] [Related]
5. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
7. Managing urinary tract infections through phage therapy: a novel approach.
Malik S; Sidhu PK; Rana JS; Nehra K
Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
[TBL] [Abstract][Full Text] [Related]
9. Characterization of auto-agglutinating and non-typeable uropathogenic Escherichia coli strains.
Hernández-Chiñas U; Pérez-Ramos A; Belmont-Monroy L; Chávez-Berrocal ME; González-Villalobos E; Navarro-Ocaña A; Eslava CA; Molina-Lopez J
J Infect Dev Ctries; 2019 Jun; 13(6):465-472. PubMed ID: 32058980
[TBL] [Abstract][Full Text] [Related]
10. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
[TBL] [Abstract][Full Text] [Related]
11. Bacteriophage therapy for
Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
[TBL] [Abstract][Full Text] [Related]
12. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
[TBL] [Abstract][Full Text] [Related]
13. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
Malik S; Nehra K; Mann A; Jagdish R; Rana JS
Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
[TBL] [Abstract][Full Text] [Related]
14. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.
Katongole P; Nalubega F; Florence NC; Asiimwe B; Andia I
BMC Infect Dis; 2020 Jun; 20(1):453. PubMed ID: 32600258
[TBL] [Abstract][Full Text] [Related]
15. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
Zalewska-Piątek BM; Piątek RJ
Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
[TBL] [Abstract][Full Text] [Related]
16. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
Harwalkar A; Gupta S; Rao A; Srinivasa H
J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
Zhao F; Yang H; Bi D; Khaledi A; Qiao M
Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
[TBL] [Abstract][Full Text] [Related]
19. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance, virulence factors and genotyping of Uropathogenic
Raeispour M; Ranjbar R
Antimicrob Resist Infect Control; 2018; 7():118. PubMed ID: 30305891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
